Read more at jarproject.org/news/2024/toro… and see this Instagram video by @_jarproject Moving towards a cure for #JIA #ThinkJIA instagram.com/reel/C8AD-4DM1… UCAN CAN-DU #CABC2024 #ConnectingJA Cassie + Friends Society Take a Pain Check Foundation susa benseler Bas Vastert Dr. Deborah A Marshall Research Team

Thank you all again for attending CABC 2024 at the beginning of this month! The photo gallery has been posted to both the UCAN CAN-DU and UCAN CURE websites ! ucancandu.com ucancure.com #CABC2024

Prof and Dean Gishan Dissanaike giving the welcome address for the Cambridge Africa Business Forum #CABC2024 #CABC24 Cambridge Judge

Visitors to the Flower Cart by Air Canada can enter a giveaway for two free tickets to Vancouver*. Don't miss this chance for unforgettable Canadian adventures! #CABCMembers #AirCanada #MothersDay #CABC2024 *Terms and conditions apply.

Thats a wrap on the 2024 Childhood Arthritis & Beyond Conference, thank you to all of our attendees for your amazing discussion over the past few days! JAR Project #ThinkJIA Cassie + Friends Society Take a Pain Check Foundation UCAN CAN-DU #CABC2024 #ConnectingJA #childhoodarthritis #scientificmeeting

Gratitude to our funders for their support that enables us to bring together brilliant minds and drive meaningful progress, Genome Alberta ! #CABC2024

Session 4: Dr. Joost Swart discusses Getting Closer to a Cure, “treatment should be adjusted until the target is achieved.” #CABC2024

Session 4: Dr. Deborah Marshall discusses how can evidence of health economics inform decision for tapering medications. Dr. Deborah A Marshall Research Team #CABC2024

Session 4: Dr. Daniel Horton discusses Current Approaches to Stopping Medications, “Biomarker guided deprescribing of medications for JIA” #CABC2024

Who could fail to be inspired by a talk with this title!! Thank you Dr Joost Swart. We are so excited by everything that the UCAN CAN-DU team are doing. #cabc24 #cabc2024 Childhood Arthritis & Beyond Conference

Dr. Deborah A Marshall Research Team talking about how health economics can inform our decisions about when to stop medications looking and patient and parent preference research within that context. Childhood Arthritis & Beyond Conference #cabc24 #cabc2024 UCAN CAN-DU

JIA subtype is a predictor of flare off medication with sJIA most likely to remain in unmedicated remission and RF positive poly-JIA least likely to remain flare-free when off medication. Daniel Horton speaking at Childhood Arthritis & Beyond Conference #cabc24 #cabc2024 UCAN CAN-DU